Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Option Care Health (OPCH) over the last 17 years, with Q3 2025 value amounting to $9.2 million.

  • Option Care Health's Capital Expenditures fell 490.23% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year decrease of 1583.58%. This contributed to the annual value of $35.6 million for FY2024, which is 1495.25% down from last year.
  • As of Q3 2025, Option Care Health's Capital Expenditures stood at $9.2 million, which was down 490.23% from $9.1 million recorded in Q2 2025.
  • In the past 5 years, Option Care Health's Capital Expenditures registered a high of $19.9 million during Q4 2023, and its lowest value of $3.1 million during Q1 2021.
  • Its 5-year average for Capital Expenditures is $8.7 million, with a median of $8.4 million in 2023.
  • Per our database at Business Quant, Option Care Health's Capital Expenditures soared by 7159.78% in 2022 and then crashed by 4800.1% in 2024.
  • Quarter analysis of 5 years shows Option Care Health's Capital Expenditures stood at $13.9 million in 2021, then surged by 31.39% to $18.2 million in 2022, then grew by 8.98% to $19.9 million in 2023, then tumbled by 48.0% to $10.3 million in 2024, then fell by 11.07% to $9.2 million in 2025.
  • Its Capital Expenditures was $9.2 million in Q3 2025, compared to $9.1 million in Q2 2025 and $9.4 million in Q1 2025.